Diretriz para análises de impacto orçamentário de tecnologias em saúde no Brasil
暂无分享,去创建一个
Rodrigo Antonini Ribeiro | Flávia Tavares Silva Elias | Andre Luis Ferreira-Da-Silva | Vânia Cristina Canuto Santos | Alexandre Lemgruber Portugal d'Oliveira | Carisi Anne Polanczyk | R. Ribeiro | F. Elias | C. Polanczyk | V. Santos | Andre Luis Ferreira-Da-Silva | Alexandre Lemgruber Portugal d'Oliveira
[1] M. Drummond,et al. Guidelines for Conducting Pharmaceutical Budget Impact Analyses for Submission to Public Drug Plans in Canada , 2012, PharmacoEconomics.
[2] T. Mittendorf,et al. Practical issues in handling data input and uncertainty in a budget impact analysis , 2010, The European Journal of Health Economics.
[3] E. Orlewska,et al. Proposal of Polish guidelines for conducting financial analysis and their comparison to existing guidance on budget impact in other countries. , 2004, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[4] Mark Nuijten,et al. Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis. , 2007, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[5] Budget impact analyses get some respect. , 2007, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[6] J R Beck,et al. Markov Models in Medical Decision Making , 1993, Medical decision making : an international journal of the Society for Medical Decision Making.
[7] Brasil. Ministério da Ciência,et al. Diretrizes metodológicas: estudos de avaliação econômica de tecnologias em saúde , 2009 .
[8] L. Gulácsi,et al. Budget-Impact Analyses , 2012, PharmacoEconomics.
[9] Departamento de Ciência e Technologia. [Health Technology Assessment: institutionalization of actions in the Brazilian Ministry of Health]. , 2006, Revista de saude publica.
[10] S. Wilson. Methods for the economic evaluation of health care programmes , 1987 .
[11] F. Rutten,et al. Combining a Budgetary-Impact Analysis and a Cost-Effectiveness Analysis Using Decision-Analytic Modelling Techniques , 2012, PharmacoEconomics.